A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Clinical trial NCT06888193 · RECRUITING

Trial details

NCT number: NCT06888193
Sponsor: UCB Biopharma SRL
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate to Severe Plaque Psoriasis Psoriatic Arthritis Axial Spondyloarthritis Hidradenitis Suppurativa

Start date: 2025-11-05
Primary completion: 2027-05-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.